$12.3B SALES IN 2023
12.7% COMPOUND ANNUAL NON-GAAP EPS GROWTH RATE SINCE 1995
Our Q1 Results Reflect
- Solid earnings driven by gross margin expansion and a strong recovery from last quarter’s cyber incident
- We continue to make good progress on executing our BOLD+1 Strategic Plan and are pleased with the contribution of our recent acquisitions
- We are affirming our expectations for 2024 non-GAAP diluted EPS and 2024 Adjusted EBITDA growth and tightening our expectations for 2024 total sales growth. Our projected sales growth reflects continued recovery from last year’s cyber incident and a strong pipeline of new specialty products and software innovation
Home tabs
At Henry Schein, Inc., our customers rely on us for an exceptional experience
Delivering differentiated solutions that make their practices more successful and improve patient outcomes. We are trusted advisors and consultants to our customers – enabling them to deliver the best quality patient care and enhance their practice management efficiency and profitability.
With more than 3,860 field sales consultants (including equipment sales specialists), approximately 1,950 telesales representatives, and more than 115 equipment sales and service centers worldwide, Henry Schein helps customers succeed by offering the products and services needed for delivering high-quality health care.
View All News
View all Quarterly Results
View all Events
Stock Information
Security: (Common)
Today's High | |
Today's Low | |
Volume |
Data Provided by Refinitiv. Minimum 15 minutes delayed.